Letter to the Editor: Leucine-rich α-2-glycoprotein in Taiwanese inflammatory bowel disease: Strengths and limitations of a novel serum marker

Figure 1 Prospective Taiwanese inflammatory bowel disease cohort and study workflow. The schematic diagram represents the single-center cohort of 203 patients (100 with ulcerative colitis, 103 with Crohn’s disease). Serum leucine-rich alpha-2 glycoprotein, C-reactive protein, hemoglobin, albumin, and fecal calprotectin were collected by the researchers within 1 month of endoscopy and analyzed against Mayo endoscopic subscore (ulcerative colitis) or Simple Endoscopic Score for Crohn’s disease as reference standards. UC: Ulcerative colitis; CD: Crohn’s disease; LGR: Leucine-rich alpha-2 glycoprotein; CRP: C-reactive protein; FC: Fecal calprotectin; MES: Mayo endoscopic subscore; SES-CD: Simple Endoscopic Score for Crohn’s disease.